Monroe Terilyn J.: insider trades.
Monroe Terilyn J. reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($7.6M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Monroe Terilyn J.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Guardant Health, Inc. (GH) | Officer · Chief People Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-12 | Guardant Health, Inc. | M | 32,288 | $20.14 | 55,267 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | S | 400 | $167.92 | 22,979 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | S | 13,248 | $166.11 | 23,379 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | S | 19,014 | $165.16 | 36,627 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | S | 9,934 | $164.27 | 55,641 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | S | 3,704 | $163.41 | 65,575 | Form 4 |
| 2026-08-12 | Guardant Health, Inc. | M | 14,012 | $28.61 | 69,279 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 2,659 | $0 | 23,717 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | M | 1,361 | $0 | 25,078 | Form 4 |
| 2026-07-01 | Guardant Health, Inc. | F | 2,099 | $170.77 | 22,979 | Form 4 |
Questions
What stock did Monroe Terilyn J. buy or sell?
Monroe Terilyn J. reported 10 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($7.6M), across 1 company.
Is Monroe Terilyn J. the same person as other filers with this name?
This page covers SEC CIK 1652956 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/monroe-terilyn-j-1652956.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.